Lv1
38 积分 2025-11-07 加入
Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies
1个月前
已完结
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc ‘spacer’ domain in the extracellular moiety of chimeric antigen receptors avoids ‘off-target’ activation and unintended initiation of an innate immune response
1个月前
已完结
A strategy of targeting B10 cell by CD19scFv-IL10R for tumor therapy
1个月前
已完结
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
1个月前
已完结
Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody
1个月前
已完结
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
1个月前
已完结
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
3个月前
已完结
Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity
3个月前
已关闭
Reshape the Fates of Treg and CD8+T Cells Through IL-2Rα by Synergizing Divergent Receptor-Biased IL-2 PEGylates
6个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
6个月前
已完结
皖公网安备34019202002308
